A
AVPTW
Avepoint Inc
7.55
1.05+16.15%Closed16:00 05/09 EDT
OPEN/PREV CLOSE7.84/6.50
TODAY RANGE7.28-8.55
VOL185.65K
MARKET CAP--
52 WEEK RANGE0.8200-8.55
AVG VOL (3M)23.74K
% TURNOVER0%
TURNOVER--
P/E (TTM)-47.6943
% RANGE19.54%
EPS(TTM)-0.1583
P/E(FORWARD)--
P/B5.44
BVPS1.387
DIVIDEND--
P/S4.434
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP--
SHARES OUTSTANDING--
NEXT EARNINGS--
FREE FLOAT--
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Reuters·05/01 08:05
U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics
Reuters·04/22 13:05
AVEPOINT INC - ANNOUNCES NEW CAPABILITIES IN ELEMENTS PLATFORM
Reuters·03/11 10:05
AVEPOINT INC <AVPT.O>: CITIGROUP CUTS TARGET PRICE TO $16 FROM $18
Reuters·03/11 07:08
U.S. RESEARCH ROUNDUP-Beam Therapeutics, Lennar, Redfin
Reuters·03/04 14:28
AVEPOINT INC <AVPT.O>: NORTHLAND CAPITAL RAISES TARGET PRICE TO $26 FROM $20
Reuters·03/04 07:27
U.S. RESEARCH ROUNDUP-California Resources, Eli Lilly, Mastec
Reuters·02/27 21:05
BRIEF-AvePoint Q4 Gross Profit USD 67.262 Million
Reuters·01/24 14:00
AVEPOINT SUBMITS APPLICATION FOR DUAL LISTING ON THE SINGAPORE EXCHANGE
Reuters·11/19/2024 14:00
AVEPOINT INTRODUCES FIRST-TO-MARKET BENCHMARKING DATA FOR MICROSOFT 365 COPILOT
Reuters·11/13/2024 11:25
AVEPOINT INC <AVPT.O>: CITIGROUP RAISES TARGET PRICE TO $17 FROM $11
Reuters·11/07/2024 21:05
BRIEF-AvePoint Q3 Gross Profit USD 67.583 Million
Same Industry
Name/Symbol
Change%
Price